首页> 外文期刊>International Journal of Pharmaceutics >Ficts and facts of epinephrine and norepinephrine stability in injectable solutions
【24h】

Ficts and facts of epinephrine and norepinephrine stability in injectable solutions

机译:注射液中肾上腺素和去甲肾上腺素稳定性的事实和事实

获取原文
获取原文并翻译 | 示例
           

摘要

Epinephrine (EPI) and norepinephrine (NE) play an important role in emergency medicine and acute treatment of hypotension and shocks in the intensive care unit. Injectable solutions can either be provided as proprietary medicinal products or as individually prepared dilutions. Due to the chemical structure of EPI and NE, the stability of the corresponding solutions is limited. Thus, most manufacturers of EPI and NE injectable solutions use sulfites and nitrogen for stabilization, Nevertheless, storage conditions such as temperature and light have to be considered, but are often neglected in the daily hospital routine. In addition, hospital pharmacies prepare EPI and NE solutions and dilute commercially available solutions for individual therapy, especially on ICUs. Since the influence of dilution and the presence of excipients and other preservatives are not systematically explored, we collected published data and investigations on stability on the potency of EPI and NE injectable solutions in order to deduce storage recommendations for diluted EPI and NE solutions of different concentration.
机译:肾上腺素(EPI)和去甲肾上腺素(NE)在重症监护病房的急诊医学和低血压和休克的急性治疗中起着重要作用。可注射溶液可以作为专有药品或单独制备的稀释液提供。由于EPI和NE的化学结构,相应溶液的稳定性受到限制。因此,大多数EPI和NE注射液制造商使用亚硫酸盐和氮气来稳定化。尽管如此,必须考虑储存条件,例如温度和光照,但在日常的医院日常工作中经常被忽略。此外,医院药房会准备EPI和NE解决方案,并稀释用于个别治疗的市售解决方案,尤其是在ICU上。由于没有系统地探讨稀释的影响以及赋形剂和其他防腐剂的存在,因此我们收集了公开的数据和稳定性对EPI和NE注射液效能的研究,以便得出不同浓度的稀释EPI和NE溶液的储存建议。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号